Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism

被引：0
|
作者：
Bo Xie
Ying Qiu
Juan Zhou
Dou Du
Haochuan Ma
Jiapeng Ji
Liquan Zhu
Weimin Zhang
机构：
[1] General Hospital of Southern Theater Command,Department of Oncology
[2] PLA,undefined
来源：
Clinical and Translational Oncology | 2022年 / 24卷
关键词：
Lorlatinib resistance; Non-small cell lung cancer; -; Mechanism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2231 / 2240
页数：9
相关论文
共 50 条
  • [1] Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism
    Xie, Bo
    Qiu, Ying
    Zhou, Juan
    Du, Dou
    Ma, Haochuan
    Ji, Jiapeng
    Zhu, Liquan
    Zhang, Weimin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (11): : 2231 - 2240
  • [2] Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
    Koizumi, F
    Shimoyama, T
    Taguchi, F
    Saijo, N
    Nishio, K
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (01) : 36 - 44
  • [3] Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line
    Chu, JJ
    Chiang, CD
    Rao, CS
    Chang, WM
    Lai, YK
    ANTICANCER RESEARCH, 2000, 20 (04) : 2449 - 2456
  • [4] Establishment and characterization of a human non-small cell lung cancer cell line
    Tai, ALS
    Fang, Y
    Sham, JST
    Deng, W
    Hu, L
    Xie, D
    Tsao, GSW
    Cheung, ALM
    Guan, XY
    ONCOLOGY REPORTS, 2005, 13 (06) : 1029 - 1032
  • [5] Establishment and characterization of non-small cell lung cancer cell line variants selected for resistance to osimertinib
    Ferguson, Peter J.
    Vincent, Mark D.
    Koropatnick, James
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Lorlatinib for the treatment of patients with non-small cell lung cancer
    Akamine, T.
    Toyokawa, G.
    Tagawa, T.
    Yamazaki, K.
    Seto, T.
    Takeo, S.
    Mori, M.
    DRUGS OF TODAY, 2019, 55 (02) : 107 - 116
  • [7] ESTABLISHMENT OF A CAMPTOTHECIN ANALOG (CPT-11)-RESISTANT CELL-LINE OF HUMAN NON-SMALL CELL LUNG-CANCER - CHARACTERIZATION AND MECHANISM OF RESISTANCE
    KANZAWA, F
    SUGIMOTO, Y
    MINATO, K
    KASAHARA, K
    BUNGO, M
    NAKAGAWA, K
    FUJIWARA, Y
    LIU, LF
    SAIJO, N
    CANCER RESEARCH, 1990, 50 (18) : 5919 - 5924
  • [8] Establishment of pemetrexed-resistant non-small cell lung cancer cell lines
    Zhang, Dan
    Ochi, Nobuaki
    Takigawa, Nagio
    Tanimoto, Yasushi
    Chen, Yanyan
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER LETTERS, 2011, 309 (02) : 228 - 235
  • [9] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [10] Overcoming Acquired Resistance to Afatinib in HCC827, a Non-small Cell Lung Cancer Cell Line
    Hsu, J.
    Lin, W.
    Lien, T.
    Chang, W.
    Sun, M.
    Jiang, S.
    Yen, K.
    Chao, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 47 - 48
12345